TREATMENT OF ANORGASMIA

Abstract

Orgasm is a feeling of intense pleasure accompanied by pelvic striated circumvaginal musculature and uterine/anal contractions and myotonia that involves sexually-induced vasocongestion, inducing well-being and contentment. Female Orgasmic Disorder, the second most frequently reported women's sexual problem is considered to be the persistent or recurrent delay in, or absence of orgasm following a normal sexual excitement phase that causes marked distress or interpersonal difficulty (DSM-IV). Empirical treatment outcome research is available for cognitive behavioral and pharmacological approaches. Cognitive-behavioral therapy for anorgasmia promotes attitude and sexually-relevant thought changes and anxiety reduction using behavioral exercises such as directed masturbation and systematic desensitization treatments as well as sex education, communication skills training and Kegel exercises. To date there are no pharmacological agents trials (i.e., bupropion, l-arginine, and sildenafil) proven to be beneficial beyond placebo in enhancing orgasmic function in women diagnosed with Female Orgasmic Disorder. More research is needed in understanding management of women with orgasmic dysfunction.